EBIT (Quarterly)

EBIT: Income before interest and taxes.

Amphastar Pharmaceuticals, Inc. (AMPH) had EBIT of $35.61M for the most recently reported fiscal quarter, ending 2025-12-31.

Quarterly Annual

Figures for fiscal quarter ending 2025-12-31

Income Statement Financials
Revenue	$183.10M
Net Income	$24.43M
Cost of Goods Sold	$97.44M
Gross Profit	$85.67M
Operating Expenses	$147.50M
Operating Income	$35.61M
Non-Operating Income/Expense	$-3.69M
Pre-Tax Income	$31.91M
Normalized Pre-Tax Income	$31.91M
Income after Taxes	$24.43M
Income from Continuous Operations	$24.43M
Consolidated Net Income/Loss	$24.43M
Normalized Income after Taxes	$24.43M
EBIT	$35.61M
EBITDA	$50.81M
Weighted-Average Shares Outstanding (Basic)	46.74M
Weighted-Average Shares Outstanding (Diluted)	48.22M
Earnings per Share (EPS) (Basic)	$0.53
Earnings per Share (EPS) (Diluted)	$0.51
Balance Sheet Financials
Current Assets	$636.02M
Property, Plant, and Equipment	$310.57M
Long-Term Assets	$993.28M
Total Assets	$1.63B
Current Liabilities	$158.16M
Long-Term Debt	$608.75M
Long-Term Liabilities	$682.34M
Total Liabilities	$840.49M
Common Equity	$788.80M
Tangible Shareholders Equity	$222.84M
Shareholders Equity	$788.80M
Common Shares Outstanding	45.65M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$156.12M
Cash Flow from Investing Activities	$-70.33M
Cash Flow from Financial Activities	$-67.42M
Beginning Cash	$151.84M
End Cash	$170.41M
Increase/Decrease in Cash	$18.57M
Stock-Based Compensation	$27.28M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	4.02
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.44
Debt to Equity Ratio	0.77
Gross Margin	46.79%
Operating Margin	19.45%
EBIT Margin	19.45%
EBITDA Margin	--
Pre-Tax Profit Margin	17.43%
Profit Margin	13.34%
Free Cash Flow	$121.23M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.11
Inventory Turnover	0.55
Receiveable Turnover	1.14
Days Sales in Receivables	79.00
Return on Equity	3.10%
Return on Tangible Equity	10.96%
Return on Assets	1.50%
Return on Investments	1.75%
Book Value Per Share	$17.28
Free Cash Flow per Share	$2.51
Operating Cash Flow per Share	$3.24

Data from Zacks Investment Research, Inc.